Document is current
Any future updates will be listed below
-
Authors
Loipfinger, Stefan
Bhattacharya, Arkajyoti
Urzúa-Traslaviña, Carlos G.
van Vugt, Marcel A. T. M.
de Bruyn, Marco
Fehrmann, Rudolf S. N.
-
Funding
Funding for this research was provided by:
KWF Kankerbestrijding (KWF-14516)
KWF Kankerbestrijding (KWF-14516)
Hanarth Fund
- License Information
-
More Information
Article History
Received: 30 June 2025
Accepted: 9 January 2026
First Online: 17 January 2026
Competing interests
: M.d.B. received grants from the Dutch Cancer Society (KWF), the European Research Council (ERC), Health Holland (HH), Mendus, BioNovion, Aduro Biotech, Vicinivax, Genmab, and IMMIOS (all paid to the institute); received non-financial support from BioNTech, Surflay Nanotec, and Merck Sharp & Dohme; is a stock option holder in Sairopa; all unrelated to the submitted work. The remaining authors declare no competing interests.
